Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T21:03:10.445Z.
Calculation as of: 2026-10-06T21:03:10.445Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 80dc1f4e8b31b1f0ec5b4a1e5c631a71efe14c3ee5142d993ef0c896d26e8132
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
Market Cap
$127.29M
EV/EBITDA Ratio
N/A
TTM Avg
3271.29x
3Y Avg
2827.81x
5Y Avg
2827.81x
Market Cap
$130.79M
EV/EBITDA Ratio
74.38x
TTM Avg
73.16x
3Y Avg
73.16x
5Y Avg
73.16x
Market Cap
$131.21M
EV/EBITDA Ratio
430.26x
TTM Avg
352.35x
3Y Avg
117.66x
5Y Avg
91.76x
Market Cap
$122.66M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pyxis Oncology, Inc. (PYXS) | $127.98M | N/A | N/A | N/A | N/A |
| NRx Pharmaceuticals, Inc. (NRXP)vs › | $127.29M | N/A | 3271.29x | 2827.81x | 2827.81x |
| Health Catalyst, Inc. (HCAT)vs › | $130.79M | 74.38x | 73.16x | 73.16x | 73.16x |
| AirSculpt Technologies, Inc. (AIRS)vs › | $131.21M | 430.26x | 352.35x | 117.66x | 91.76x |
| Entera Bio Ltd. (ENTX)vs › | $124.70M | N/A | 3.93x | 3.93x | 3.93x |
| TuHURA Biosciences, Inc. (HURA)vs › | $124.18M | N/A | N/A | N/A | N/A |
| LifeMD, Inc. (LFMD)vs › | $132.03M | N/A | 53.44x | 53.44x | 53.44x |
| Tonix Pharmaceuticals Holding Corp. (TNXP)vs › | $122.66M | N/A | N/A | N/A | N/A |
| Freenome, Inc. (FRNM)vs › | $133.45M | N/A | N/A | N/A | N/A |
| BGM Group Ltd. (BGM)vs › | $122.43M | N/A | N/A | N/A | N/A |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
